Drug:
Reaction: DRUG INEFFECTIVE
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26555940 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 102 | 26555941 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 103 | 26555943 |
US |
34 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 104 | 26555944 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 105 | 26555945 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 106 | 26555946 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 107 | 26555948 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 108 | 26555950 |
US |
43 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 109 | 26555951 |
US |
45 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 110 | 26555952 |
US |
32 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 111 | 26555980 |
CA |
||
Nephrolithiasis, Drug ineffective, Hyperhidrosis, Nausea, Off label use, Product use in unapproved indication, Sedation, Nightmare, |
||||
DICLOFENAC SODIUM, ESOMEPRAZOLE MAGNESIUM, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, CELECOXIB, MEPERIDINE HYDROCHLORIDE, OXYCODONE AND ACETAMINOPHEN, HYDROMORPHONE HYDROCHLORIDE, RIZATRIPTAN BENZOATE, MORPHINE SULFATE, ONDANSETRON HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, ATENOLOL AND CHLORTHALIDONE, DULOXETINE HYDROCHLORIDE, DULOXETINE, TOPIRAMATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALMOTRIPTAN, ALMOTRIPTAN MALATE, ONABOTULINUMTOXINA, BOTULINUM TOXIN TYPE A, GABAPENTIN, |
||||
| 112 | 26556063 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 113 | 26556064 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 114 | 26556066 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 115 | 26556069 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 116 | 26556072 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 117 | 26556073 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 118 | 26556074 |
AR |
66 | 2 |
Anal incontinence, Rectal haemorrhage, Hepatitis, Skin burning sensation, Swollen tongue, Mouth swelling, Eating disorder, Pain, Rash, Pruritus, Exfoliative rash, Decreased immune responsiveness, Colostomy bag user, Acne pustular, Ill-defined disorder, Rash macular, Erythema, Blister, Malaise, Discomfort, Skin haemorrhage, Dysarthria, Drug ineffective, Dry skin, Off label use, Drug hypersensitivity, Flatulence, Blood test abnormal, Magnetic resonance imaging abnormal, Therapy interrupted, Musculoskeletal pain, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, |
||||
| 119 | 26556086 |
US |
59 | 1 |
Off label use, Gout, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 120 | 26556089 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 121 | 26556090 |
US |
69 | 1 |
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 122 | 26556098 |
EU |
53 | |
Psoriatic arthropathy, Muscle rigidity, Drug ineffective, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, METHOTREXATE SODIUM, VALPROATE SODIUM, |
||||
| 123 | 26556115 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 124 | 26556116 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 125 | 26556120 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 126 | 26556132 |
CA |
74 | |
Spinal disorder, Drug intolerance, Asthenia, Dizziness, Pruritus, Nausea, Drug ineffective, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, ADALIMUMAB-ADAZ, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 127 | 26556137 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 128 | 26556138 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 129 | 26556143 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 130 | 26556144 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 131 | 26556148 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 132 | 26556149 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 133 | 26556150 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 134 | 26556158 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 135 | 26556159 |
US |
||
Drug effect less than expected, Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 136 | 26556162 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 137 | 26556165 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 138 | 26556172 |
US |
64 | 2 |
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 139 | 26556189 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 140 | 26556191 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 141 | 26556192 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 142 | 26556213 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 143 | 26556214 |
US |
62 | |
Drug ineffective, Drug effect less than expected, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 144 | 26556215 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 145 | 26556217 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 146 | 26556219 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 147 | 26556243 |
US |
26 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 148 | 26556244 |
US |
24 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 149 | 26556245 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 150 | 26556288 |
US |
53 | |
Drug ineffective, |
||||
ROCURONIUM, ROCURONIUM BROMIDE, ROCURONIUM, ROCURONIUM BROMIDE, ROCURONIUM, ROCURONIUM BROMIDE, |
||||
| 151 | 26556292 |
US |
2 | |
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 152 | 26556304 |
US |
37 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 153 | 26556306 |
US |
47 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 154 | 26556307 |
US |
39 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 155 | 26556308 |
US |
30 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 156 | 26556309 |
US |
37 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 157 | 26556310 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 158 | 26556311 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 159 | 26556335 |
US |
48 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 160 | 26556339 |
US |
47 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 161 | 26556344 |
US |
42 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 162 | 26556345 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 163 | 26556349 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 164 | 26556353 |
US |
36 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 165 | 26556354 |
US |
||
Injection site pain, Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 166 | 26556355 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 167 | 26556356 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 168 | 26556357 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 169 | 26556358 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 170 | 26556359 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 171 | 26556360 |
US |
59 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 172 | 26556361 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 173 | 26556362 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 174 | 26556366 |
US |
2 | |
Drug ineffective, |
||||
ABATACEPT, |
||||
| 175 | 26556369 |
US |
58 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 176 | 26556371 |
US |
40 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 177 | 26556372 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 178 | 26556373 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 179 | 26556374 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 180 | 26556375 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 181 | 26556385 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 182 | 26556386 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 183 | 26556388 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 184 | 26556389 |
US |
||
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 185 | 26556394 |
US |
64 | 2 |
Drug ineffective, |
||||
ETANERCEPT, |
||||
| 186 | 26556416 |
US |
45 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 187 | 26556417 |
US |
40 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 188 | 26556419 |
US |
55 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 189 | 26556445 |
US |
35 | |
Drug ineffective, Product preparation issue, Incorrect dose administered, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 190 | 26556448 |
US |
30 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 191 | 26556449 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 192 | 26556450 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 193 | 26556452 |
US |
39 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, |
||||
| 194 | 26556454 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, ONABOTULINUMTOXINA, |
||||
| 195 | 26556471 |
US |
1 | |
Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 196 | 26556473 |
US |
49 | |
Drug ineffective, Off label use, |
||||
PRABOTULINUM TOXIN TYPE A, PRABOTULINUM TOXIN TYPE A, ONABOTULINUMTOXINA, |
||||
| 197 | 26556474 |
US |
55 | |
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 198 | 26556475 |
US |
||
Drug ineffective, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 199 | 26556477 |
US |
50 | |
Drug ineffective, Drug effect less than expected, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
| 200 | 26556478 |
US |
45 | |
Drug ineffective, Product preparation error, |
||||
PRABOTULINUM TOXIN TYPE A, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28